Displaying 1-9 of 9 result(s).
| Board Name | Posts By JoJoWitNoMoJo | Post Created |
|---|---|---|
| OWCP OWC Pharmaceutical Research Corp. | I never recommend the other stock I  (1) | 03/21/2018 2:05:14 AM |
| OWCP OWC Pharmaceutical Research Corp. | So that’s why my post was deleted (1) | 03/20/2018 6:05:11 PM |
| OWCP OWC Pharmaceutical Research Corp. | WOW. I left Lie-Hub because of the | 03/20/2018 11:04:59 AM |
| OWCP OWC Pharmaceutical Research Corp. | Just wish some tech minded individu | 03/12/2018 2:16:11 PM |
| OWCP OWC Pharmaceutical Research Corp. | Just a reminder... Each one of thes | 03/08/2018 10:32:46 PM |
| OWCP OWC Pharmaceutical Research Corp. | Its late and my head is a little fr | 03/07/2018 11:10:12 PM |
| OWCP OWC Pharmaceutical Research Corp. | Don't hold your breath moxaman, I e (2) | 03/07/2018 1:43:57 PM |
| OWCP OWC Pharmaceutical Research Corp. | https://businessden.com/2018/03/07 | 03/07/2018 1:20:31 PM |
| OWCP OWC Pharmaceutical Research Corp. | Most know that big Pharma is the re | 03/05/2018 7:49:37 PM |
Recent Articles
- Ayvens Reports Remarkable Q2 2025 Performance Results
- Flow Traders Reports Outstanding Growth in 2Q 2025 Results
- Examining DSV's Solid Financial Performance and Future Outlook
- Stargate Norway: A New Era in AI Infrastructure Begins
- Betolar and Mandalay Forge Green Solutions for Mining Sector
- Azentio Enhances Boubyan Bank's Digital Transformation Journey
- Visa's Resilient Performance Amid Market Confusion Explained
- Bekaert's Strategic Share Buyback Initiative for Growth
- Microsoft's Satya Nadella Reflects on Netflix and AI's Future
- Nscale and Aker ASA Team with OpenAI for AI Project
- Exploring Stargate Norway: A New Era in AI Infrastructure
- Aker ASA and Nscale Launch Exciting AI Initiative in Norway
- argenx SE Achieves Significant Growth in Half-Year 2025 Results
- Planisware Reports Robust H1 2025 Financial Performance
- Renault Group's Momentum Builds for Future Growth and Stability
- Fagron's Growth Trajectory in Half-Year Performance Review
- Bekaert's H1 2025 Financial Performance Analysis
- ArcelorMittal's Impressive Growth and Financial Resilience in Q2 2025
- Renault SA Announces H1 Financial Report Availability
- Impinj Experiences a 22% Surge Following Impressive Q2 Results
- Federal Reserve Decision Sparks Diverse Market Reactions
- SPIE Reports Strong 2025 Half-Year Results with Growth and M&A
- JCDecaux Reports Strong Half-Year 2025 Results with Digital Growth
- EfTEN Real Estate Fund Delivers Strong Q2 Results in 2025
- ING Reports Impressive 2Q2025 Financial Performance Growth
- AS Ekspress Grupp Reports Growth Amid Economic Challenges
- Crédit Agricole S.A.'s Strong Growth and Future Plans Unveiled
- Syensqo Announces Launch of New Share Buyback Tranche
- Ipsen's Strong Half-Year Performance Leads to Positive Guidance
- Bekaert's Upcoming Share Buyback Program and Insights
- Corbion's Impressive H1 2025 Results Showcase Growth
- Pharming Group's Financial Upsurge: Q2 Highlights and Future Outlook
- Clariant Q2 2025: Profit Margins Rise Amid Market Challenges
- Ontex Delivers Mixed Results Amid Market Challenges and Changes
- Arcadis Reports Strong Q2 and Half Year 2025 Performance
- dsm-firmenich Showcases Robust H1 2025 Performance and Vision
- AS Ekspress Grupp Reports Positive Growth Amid Economic Pressures
- SCOR Reports Strong Q2 2025 Financial Performance with EUR 226M Gain
- Empowering Youth Against Corruption: ICAC's Landmark Program
- Cyberattacks Continue to Surge: Insights from Semperis Study
- Renault SA Announces 2025 H1 Financial Report Availability
- SCOR Reports Impressive Second Quarter Results with EUR 226M Income
- Ipsen's Robust Half-Year Performance and Optimistic Outlook
- Ontex's Strategic Shift Amidst H1 Revenue Challenges
- Syensqo Reports Strong Q2 Performance Amid Challenges
- argenx Achieves Milestones in 2025: Q2 Financial Highlights
- dsm-firmenich Achieves Strong Growth in H1 2025 Results
- Arcadis Reports Strong Q2 and Half-Year Results for 2025
- Clariant's Q2 2025: Resilient Profitability Amidst Challenges
- Pharming Group Achieves Impressive Revenue Growth in 2025